Sponsor:
National Institutes of Health
UI Contact:
Updated Date:
Feb 1, 2021
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:
Policy Notices
- Notice of Legislative Mandates in Effect for FY 2021
National Institutes of Health - Guidance on Salary Limitation for Grants and Cooperative Agreements FY 2021
National Institutes of Health - Notice of Fiscal Policies in Effect for FY 2021
National Institutes of Health
General Notices
- Notice of Pre-Application Information Webinar and Frequently Asked Questions (FAQs) for RFA-DA-21-020, RFA-DA-21-021, RFA-DA-21-022, and RFA-DA-21-023
National Institute on Drug Abuse - Notice of Clarification of Award Budget for RFA-HD-21-023, NICHD Program Project Grants for HIV Research (P01 Clinical Trial Optional)
Eunice Kennedy Shriver National Institute of Child Health and Human Development - Ruth L. Kirschstein National Research Service Award (NRSA) Stipends, Tuition/Fees and Other Budgetary Levels Effective for Fiscal Year 2021
National Institutes of Health
Agency for Healthcare Research and Quality
Health Resources and Services Administration - Notice of Intent to Publish a Funding Opportunity Announcement for Advancing Gender Inclusive Excellence (AGIE) Coordinating Center (U54)
Office of Research on Women's Health
National Institute of Diabetes and Digestive and Kidney Diseases - Notice of Pre-Application Webinar for the Common Funds Nutrition for Precision Health Program RFAs.
Office of Strategic Coordination (Common Fund) - Notice of Change to Key Dates for RFA-RM-21-009 "Cellular Senescence Network: Technology Development and Application (UG3/UH3 Clinical Trial Not Allowed)"
Office of Strategic Coordination (Common Fund) - Notice of Change to Key Dates for RFA-RM-21-010 "Cellular Senescence Network: Consortium Organization and Data Coordinating Center (U24 Clinical Trial Not Allowed)"
Office of Strategic Coordination (Common Fund)
Notice of Changes to Funding Opportunities
- Notice of NIAID's Participation in PAR-19-039: Countermeasures Against Chemical Threats (CounterACT): Identification of Therapeutic Lead Compounds (U01 Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases - Notice of NIAID's Participation in PAR-19-040: Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01 Clinical Trial Optional)
National Institute of Allergy and Infectious Diseases - Notice of NIAID's Participation in PAR-20-253: Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects (R21 Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases - Notice of NIAID's Participation in PAR-20-316: NIH Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 - Clinical Trial Optional)
National Institute of Allergy and Infectious Diseases - Notice of Change to RFA-DA-21-016, "Novel Approaches to Decrease Stigma of Substance Use Disorders in order to Facilitate Prevention, Treatment, and Support During Recovery (R43/R44 - Clinical Trials Optional)"
National Institute on Drug Abuse - Notice of NIDA's Participation in NOT- MD-21-008 "Notice of Special Interest (NOSI): Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities"
National Institute on Drug Abuse - Notice of change to Eligible Organizations under RFA-FD-21-023 "National Food and Nutrient Analysis Program (U01) Clinical Trial Not Applicable"
Food and Drug Administration - Notice of Change to Key Dates for Cellular Senescence Network (SenNet) RFA-RM-21-008 "Cellular Senescence Network: Tissue Mapping Centers (U54 Clinical Trial Not Allowed)"
Office of Strategic Coordination (Common Fund) - Notice of Termination of RFA-TR-20-030 "Multi-disciplinary Machine-assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey (UG3/UH3 Clinical Trial Not Allowed)
National Center for Advancing Translational Sciences
Notices of Intent to Publish
- Notice of Intent to Publish a Funding Opportunity Announcement for SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trials Not Allowed)
National Institute on Alcohol Abuse and Alcoholism - Notice of Intent to Publish a Funding Opportunity Announcement for SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trials Not Allowed)
National Institute on Alcohol Abuse and Alcoholism - Notice of Intent to Publish a Funding Opportunity Announcement for SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trials Not Allowed)
National Institute on Alcohol Abuse and Alcoholism - Notice of Intent to Publish Funding Opportunity Announcements for Research on Firearm Injury and Mortality Prevention
Office of Behavioral and Social Sciences Research
Notices of Special Interest
- Notice of Special Interest (NOSI): Aging-Relevant Behavioral and Social Research on Coronavirus Disease 2019 (COVID-19)
National Institute on Aging - Notice of Special Interest (NOSI): Leveraging Real-World Imaging Data for Artificial Intelligence-based Modeling and Early Detection of Abdominal Cancers
National Cancer Institute - Notice of Special Interest (NOSI): Understanding the effects of cancer and cancer treatment on aging trajectories and aging outcomes
National Cancer Institute
National Institute on Aging - Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection
National Institute on Drug Abuse - Notice of Special Interest (NOSI): High-Priority Interest to Enhance Data Science Research Training in Addiction Research
National Institute on Drug Abuse - Notice of Special Interest (NOSI): NIDCR Support for Research on the Physiological Involvement of Oral Cavity in Coronavirus Disease 2019 (COVID-19)
National Institute of Dental and Craniofacial Research
Funding Opportunities
- NIA MSTEM: Advancing Diversity in Aging Research through Undergraduate Education (R25 - Independent Clinical Trial Not Allowed)
National Institute on Aging
- NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed)
National Institute on Aging
- NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Pre-Clinical Research (R44 Clinical Trial Not Allowed)
National Institute of Neurological Disorders and Stroke
- The Cellular Scale Connectome in Aging and Alzheimers Disease (U01 Clinical Trial Not Allowed)
National Institute on Aging
- NIH Blueprint for Neuroscience Research: Tools and Technologies to Explore Nervous System Biomolecular Condensates (R21 Clinical Trial Not Allowed)
National Institute on Drug Abuse
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Office of Behavioral and Social Sciences Research
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 335-2123, or email Carrie Damon at carolyn-damon@uiowa.edu or Dave Myers at dave-myers@uiowa.edu or Lynn Hudachek at lynn-hudachek @uiowa.edu.